Innovation Means Hope: DIOMEDES - a better outlook for Glioblastoma patients

Brain tumours can happen at any age and there are many types. Glioblastoma the most aggressive: Only about 3 in 100 patients survive more than 5 years - more research is essential to ensure more patients survive. The project DIOMEDES aims to develop personalised therapies that will reduce the high mortality rate of this disease.

See/hear project leaders Anna Golebiewska and Petr Nazarov (Luxembourg Institute of Health) introduce the research project DIOMEDES, co-funded with €510,000 from Fondation Cancer Luxembourg and the FNR, in the framework of the FNR’s CORE programme, which supports research projects in priority areas for Luxembourg.

Videos produced with Super8 videos.
Be the first to comment